Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | CDC25A | P30304 | 2/20 | 0.43 |
| ▸ | APOBEC3A | P31941 | 4/20 | 0.41 |
| ▸ | APOBEC3G | Q9HC16 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methoxyacetic Acid SCHEMBL17418385 | 0.98 | KDM4E (0.65) | KDM4ECDC25AAPOBEC3AAPOBEC3GLMNA | |
| Methoxyacetic Acid SCHEMBL17418161 | 0.87 | KDM4E (0.46) | KDM4ECDC25AAPOBEC3AAPOBEC3GLMNA | |
| Methoxyacetic Acid SCHEMBL17418244 | 0.86 | KDM4E (0.43) | KDM4ECDC25AAPOBEC3AAPOBEC3GLMNA | |
| Methoxyacetic Acid SCHEMBL17418358 | 0.86 | KDM4E (0.49) | KDM4ECDC25AAPOBEC3AAPOBEC3GLMNA | |
| Methoxyacetic Acid SCHEMBL17418261 | 0.85 | CDC25A (0.48) | KDM4ECDC25AAPOBEC3AAPOBEC3GALDH1A1 | |
| Methoxyacetic Acid SCHEMBL17418877 | 0.85 | KDM4E (0.46) | KDM4ECDC25AAPOBEC3AAPOBEC3GLMNA | |
| Methoxyacetic Acid SCHEMBL17418315 | 0.83 | BBOX1 (0.46) | KDM4ECDC25AAPOBEC3AAPOBEC3GLMNA | |
| Methoxyacetic Acid SCHEMBL17418625 | 0.82 | KDM4E (0.37) | KDM4ECDC25AAPOBEC3AAPOBEC3GLMNA | |
| Methoxyacetic Acid SCHEMBL17418451 | 0.82 | LMNA (0.48) | KDM4ECDC25AAPOBEC3AAPOBEC3GLMNA | |
| SCHEMBL372602 | 0.81 | KDM4E (0.91) | KDM4ECDC25AAPOBEC3AAPOBEC3GLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10087155-B2 | Onium salt, liquid composition containing said onium salt and cellulose, and cellulose recovery method | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2018-10-02 | — | — | US | disclosed |
| US-20160009669-A1 | ONIUM SALT, LIQUID COMPOSITION CONTAINING SAID ONIUM SALT AND CELLULOSE, AND CELLULOSE RECOVERY METHOD | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2016-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160009669-A1 | ONIUM SALT, LIQUID COMPOSITION CONTAINING SAID ONIUM SALT AND CELLULOSE, AND CELLULOSE RECOVERY METHOD | CEL, CROCC, ALG1 | KDM4E 1130/4885CDC25A 2218/4885APOBEC3A 2939/4885 |
| US-10087155-B2 | Onium salt, liquid composition containing said onium salt and cellulose, and cellulose recovery method | CEL, CROCC, ALG1 | KDM4E 1130/4885CDC25A 2218/4885APOBEC3A 2939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.